FDA Approves Expanded Use of Smallpox Vaccine for High-Risk Mpox Patients
Cigna to Remove Humira from Formularies in 2025, Favoring Biosimilars
Texas Court Strikes Down FTC's Noncompete Ban as Overreach
Launch Week, Day 2: Pyrls Expands Knowledge Center with Free Top 200 Drugs Flashcards for Health Professional Programs
Genentech to Discontinue Fuzeon® (Enfuvirtide) Amid Evolving HIV Treatment Landscape
Free At-Home COVID-19 Test Kits Return for Fall 2024: What Pharmacists Need to Know
Pyrls.com Expands Drug Information Access with Over 1,700 AHFS Monographs
Dexcom's Stelo: First Over-the-Counter Wearable Glucose Biosensor Enters Market
Nine-Year Sentence for Leader of HIV Medication Fraud Scheme
FDA Approves First Nasal Spray for Anaphylaxis Treatment
FTC Finalizes Nationwide Ban on Noncompete Agreements
CVS Health to Cover Over-the-Counter Birth Control Pill Opill at No Cost
Revolutionizing Prescription Practices: The Emergence of DrugGPT in England's Healthcare
Subscribe
Our newsletter brings you the latest news, updates, and insights directly to your inbox. Our carefully curated content is designed to keep you at the forefront of Pharmacy.
FDA Approves Expanded Use of Smallpox Vaccine for High-Risk Mpox Patients
Cigna to Remove Humira from Formularies in 2025, Favoring Biosimilars
Texas Court Strikes Down FTC's Noncompete Ban as Overreach